bioprocessing API supplier

  • Recombinant Carboxypeptidase B (CPB) enzyme for pharmaceutical and research applications

    Recombinant Carboxypeptidase B (rCPB) GMP Enzyme for Insulin Purification & Bioprocessing

    .hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

    Recombinant Carboxypeptidase B (rCPB) GMP Enzyme for Insulin Purification & Bioprocessing

    Recombinant Carboxypeptidase B GMP Grade Enzyme API Supplier

    Our Recombinant Carboxypeptidase B (rCPB) represents a breakthrough in enzymatic biotechnology, offering pharmaceutical manufacturers a highly pure and efficient solution for precision protein processing. As a zinc-containing exopeptidase, rCPB specifically catalyzes the cleavage of C-terminal basic amino acids (arginine and lysine), making it indispensable in the production of recombinant insulin and other therapeutic proteins. Through advanced recombinant DNA technology, we have engineered a superior enzyme with exceptional catalytic efficiency, thermal stability, and lot-to-lot consistency that far exceeds traditional pancreatic extracts.

    Manufactured under stringent cGMP conditions with comprehensive international certifications including ISO 9001, ISO 22000, HACCP, HALAL, GMPC, and U.S. GRAS recognition, our rCPB guarantees exceptional purity (>98% by HPLC), minimal protease contamination, and reliable performance in critical bioprocessing applications. The recombinant production method eliminates risks associated with animal-derived enzymes, ensuring superior safety profiles and compliance with evolving regulatory requirements for biopharmaceutical manufacturing. Each batch undergoes rigorous characterization including mass spectrometry, peptide mapping, and functional activity assays to verify structural integrity and biological performance.

    The global insulin market continues to expand rapidly, driving increased demand for high-quality processing enzymes that can improve yields, reduce production costs, and ensure final product quality. Our rCPB is specifically optimized for the conversion of proinsulin to insulin, efficiently removing C-terminal basic residues with remarkable specificity and speed. Beyond insulin manufacturing, this versatile enzyme finds applications in protein sequencing, peptide mapping, and the production of various biotherapeutics requiring C-terminal modification. With flexible packaging options and comprehensive technical support, we provide pharmaceutical partners with the reliable enzyme solutions needed to advance their bioprocessing capabilities and maintain competitive advantage in global markets.

      Request Product Information

      Please share your requirements below.



      * B2B inquiries only
      * Confidential information protected
      * No spam or marketing emails

      Read moreDone
    • Recombinant KexII Protease enzyme for precise protein cleavage in pharmaceutical and biotechnological applications

      Recombinant KexII Protease API GMP Grade for Precision Protein Processing & Biopharma

      .hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

      Recombinant KexII Protease API GMP Grade for Precision Protein Processing & Biopharma

      Recombinant KexII Protease GMP Enzyme for Biopharmaceutical Manufacturing

      Recombinant KexII Protease represents a cutting-edge enzymatic solution for precision processing in biopharmaceutical manufacturing. As a calcium-dependent serine protease belonging to the subtilisin family, KexII specifically recognizes and cleaves at paired basic residues (KR- and RR- sites), making it indispensable for the activation of pro-proteins and maturation of recombinant therapeutic peptides. Our recombinant version, produced through advanced microbial expression systems, delivers superior purity, consistency, and activity compared to traditional native preparations, ensuring reliable performance in critical bioprocessing applications.

      Manufactured under stringent cGMP conditions with comprehensive international certifications including ISO 9001, ISO 22000, HACCP, HALAL, GMPC, and U.S. GRAS recognition, our Recombinant KexII Protease guarantees exceptional quality and safety profiles. The enzyme demonstrates remarkable specificity for dibasic cleavage sites while maintaining minimal non-specific proteolytic activity, making it ideal for processing sensitive biopharmaceutical products where precise cleavage is paramount. Through rigorous quality control measures including mass spectrometry, peptide mapping, and functional activity assays, we ensure each batch meets the highest standards for pharmaceutical applications.

      The global biopharmaceutical market’s rapid expansion, particularly in peptide-based therapeutics and recombinant protein drugs, has created significant demand for high-quality processing enzymes like KexII Protease. Our enzyme is specifically optimized for critical applications including pro-insulin conversion, monoclonal antibody processing, and the activation of various recombinant therapeutic proteins. With its robust performance across diverse pH and temperature conditions, and excellent stability in various buffer systems, our Recombinant KexII Protease enables manufacturers to achieve higher yields, improved product quality, and reduced production costs. Backed by comprehensive technical support and flexible packaging options, we provide biopharmaceutical partners with reliable enzymatic solutions that drive innovation and maintain competitive advantage in global markets.

        Request Product Information

        Please share your requirements below.



        * B2B inquiries only
        * Confidential information protected
        * No spam or marketing emails

        Read moreDone